0.438734 	 (+): Aryldialkylphosphatase  IC
0.438132 	 (+): Intracranial Aneurysm
0.438132 	 (+): Light
0.437534 	 (+): Anti-Inflammatory Agents
0.437534 	 (+): Antiplatyhelmintic Agents
0.437534 	 (+): Atherosclerosis
0.437534 	 (+): Cause of Death
0.437534 	 (+): Cell Proliferation
0.437534 	 (+): Genome-Wide Association Study
0.437534 	 (+): Heart
0.437534 	 (+): Heart Arrest    O
0.437534 	 (+): Hypothermia, Induced
0.437534 	 (+): Immunologic Factors
0.437534 	 (+): Kidney Diseases
0.437534 	 (+): Oligonucleotide Array Sequence Analysis
0.437534 	 (+): Patient Discharge
0.437534 	 (+): Phosphodiesterase 3 Inhibitors
0.437534 	 (+): Quinazolinones
0.437534 	 (+): Renal Insufficiency, Chronic
0.437534 	 (+): Stainless Steel
0.436695 	 (-): ADAM Proteins
0.436695 	 (-): Acetylcysteine
0.436695 	 (-): Adrenergic beta-1 Receptor Antagonists
0.436695 	 (-): Aging
0.436695 	 (-): Amlodipine
0.436695 	 (-): Aneurysm
0.436695 	 (-): Angioplasty, Balloon, Laser-Assisted
0.436695 	 (-): Angiotensin-Converting Enzyme Inhibitors
0.436695 	 (-): Antidepressive Agents
0.436695 	 (-): Anxiety Disorders
0.436695 	 (-): Aortic Valve
0.436695 	 (-): Arteriosclerosis
0.436695 	 (-): Atenolol
0.436695 	 (-): Bisoprolol
0.436695 	 (-): Brachytherapy
0.436695 	 (-): Brain Diseases
0.436695 	 (-): Caffeine
0.436695 	 (-): Captopril
0.436695 	 (-): Carbon Isotopes
0.436695 	 (-): Cardiopulmonary Bypass
0.436695 	 (-): Carotid Arteries
0.436695 	 (-): Carotid Artery Diseases
0.436695 	 (-): Cell Count
0.436695 	 (-): Cell Degranulation
0.436695 	 (-): Cerebral Arterial Diseases
0.436695 	 (-): Cerebral Hemorrhage
0.436695 	 (-): Cerebral Revascularization
0.436695 	 (-): Cerebrovascular Circulation
0.436695 	 (-): Chemokines
0.436695 	 (-): Citalopram
0.436695 	 (-): Clopidol
0.436695 	 (-): Cyclic GMP
0.436695 	 (-): Cyclooxygenase 1
0.436695 	 (-): Cyclooxygenase 2
0.436695 	 (-): Deamino Arginine Vasopressin
0.436695 	 (-): Depressive Disorder
0.436695 	 (-): Diabetes Mellitus, Type 1
0.436695 	 (-): Diabetic Nephropathies
0.436695 	 (-): Diagnostic Techniques, Cardiovascular
0.436695 	 (-): Dihydropyridines
0.436695 	 (-): Embolism, Cholesterol
0.436695 	 (-): Enalapril
0.436695 	 (-): European Continental Ancestry Group
0.436695 	 (-): Exercise
0.436695 	 (-): Fatty Acids, Omega-3
0.436695 	 (-): Free Radicals
0.436695 	 (-): Gene Expression Regulation
0.436695 	 (-): Glycemic Index
0.436695 	 (-): Heart Defects, Congenital
0.436695 	 (-): Heart Septal Defects, Atrial
0.436695 	 (-): Heart Valve Prosthesis
0.436695 	 (-): Hemodynamics
0.436695 	 (-): Heparin, Low-Molecular-Weight
0.436695 	 (-): Hyperemia
0.436695 	 (-): Hypericum
0.436695 	 (-): Image Cytometry
0.436695 	 (-): Imines
0.436695 	 (-): Infarction, Middle Cerebral Artery
0.436695 	 (-): Inflammation Mediators
0.436695 	 (-): Intermittent Claudication
0.436695 	 (-): Lateral Ventricles
0.436695 	 (-): Leg
0.436695 	 (-): Leukocytes, Mononuclear
0.436695 	 (-): Liver Diseases
0.436695 	 (-): Medicine, Chinese Traditional
0.436695 	 (-): Membrane Glycoproteins
0.436695 	 (-): Metoprolol
0.436695 	 (-): Monitoring, Intraoperative
0.436695 	 (-): Myocardial Perfusion Imaging
0.436695 	 (-): Naphthalenes
0.436695 	 (-): Nifedipine
0.436695 	 (-): Nitric Oxide
0.436695 	 (-): Nortriptyline
0.436695 	 (-): Percutaneous Coronary Intervention
0.436695 	 (-): Phenprocoumon
0.436695 	 (-): Preventive Medicine
0.436695 	 (-): Prolactin
0.436695 	 (-): Propionates
0.436695 	 (-): Ramipril
0.436695 	 (-): Receptors, Adrenergic, beta-2
0.436695 	 (-): Receptors, Cell Surface
0.436695 	 (-): Receptors, Cytoplasmic and Nuclear
0.436695 	 (-): Receptors, Thromboxane
0.436695 	 (-): Salicylates
0.436695 	 (-): Serotonin Uptake Inhibitors
0.436695 	 (-): Sertraline
0.436695 	 (-): Statistical Distributions
0.436695 	 (-): Stress, Physiological
0.436695 	 (-): Stroke Volume
0.436695 	 (-): Substance Withdrawal Syndrome
0.436695 	 (-): Sulfonylurea Compounds
0.436695 	 (-): Thiazolidinediones
0.436695 	 (-): Thienopyridines
0.436695 	 (-): Tomography, Emission-Computed, Single-Photon
0.436695 	 (-): Tranexamic Acid
0.436695 	 (-): Transcription Factors
0.436695 	 (-): Tumor Necrosis Factor-alpha
0.436695 	 (-): Vasculitis
0.436695 	 (-): Ventricular Dysfunction, Left
0.436695 	 (-): Yohimbine
0.436449 	 (-): Adrenergic alpha-Antagonists
0.436449 	 (-): Adrenergic beta-Antagonists
0.436449 	 (-): Antithrombins
0.436449 	 (-): Breath Tests
0.436449 	 (-): Cardiovascular Surgical Procedures
0.436449 	 (-): Circadian Rhythm
0.436449 	 (-): Depression
0.436449 	 (-): Drugs, Generic
0.436449 	 (-): Erythropoietin
0.436449 	 (-): Factor VIIa
0.436449 	 (-): Fibrinolysis
0.436449 	 (-): Heart-Assist Devices
0.436449 	 (-): Hematologic Tests
0.436449 	 (-): Histamine H2 Antagonists
0.436449 	 (-): Insulin
0.436449 	 (-): Intracranial Embolism
0.436449 	 (-): Intraoperative Complications
0.436449 	 (-): Phosphodiesterase Inhibitors
0.436449 	 (-): Platelet Transfusion
0.436449 	 (-): Postoperative Care
0.436449 	 (-): Ranitidine
0.436449 	 (-): Receptor, PAR-1
0.436449 	 (-): Receptors, Adrenergic, alpha-2
0.436449 	 (-): Renal Dialysis
0.436449 	 (-): Rifampin
0.436449 	 (-): Thromboplastin
0.436449 	 (-): Tomography, X-Ray Computed
0.436449 	 (-): Triglycerides
0.436449 	 (-): Vascular Diseases
0.436449 	 (-): Warfarin
0.436203 	 (-): Atherectomy
0.436203 	 (-): Bayes Theorem
0.436203 	 (-): Blood Platelet Disorders
0.436203 	 (-): Databases, Factual
0.436203 	 (-): Endarterectomy, Carotid
0.436203 	 (-): Enoxaparin
0.436203 	 (-): Enzyme Inhibitors
0.436203 	 (-): Exercise Test
0.436203 	 (-): Hemostasis
0.436203 	 (-): Hypoglycemic Agents
0.436203 	 (-): Intracranial Arteriosclerosis
0.436203 	 (-): Monocytes
0.436203 	 (-): Recovery of Function
0.436203 	 (-): Thrombophilia
0.436203 	 (-): Ultrasonography, Doppler, Transcranial
0.435956 	 (-): Antigens, Human Platelet
0.435956 	 (-): Blood Coagulation Factors
0.435956 	 (-): Blood Vessel Prosthesis Implantation
0.435956 	 (-): Calcium
0.435956 	 (-): Cell Adhesion
0.435956 	 (-): Dipyridamole
0.435956 	 (-): Fluorobenzenes
0.435956 	 (-): Hemorheology
0.435956 	 (-): Pyrimidines
0.43571 	 (-): Algorithms
0.43571 	 (-): Cerebral Infarction
0.43571 	 (-): Heart Failure
0.43571 	 (-): Postoperative Hemorrhage
0.43571 	 (-): Pyridines
0.43571 	 (-): Thromboembolism
0.43571 	 (-): Thromboxane B2
0.435463 	 (-): Anticholesteremic Agents
0.435463 	 (-): Calcium Channel Blockers
0.435463 	 (-): Patient Selection
0.435463 	 (-): Receptors, Thrombin
0.435216 	 (-): Platelet Adhesiveness
0.434969 	 (-): Antigens, CD
0.434969 	 (-): Diabetes Mellitus
0.434969 	 (-): Diabetic Angiopathies
0.434969 	 (-): Endothelium, Vascular
0.434969 	 (-): Hirudins
0.434969 	 (-): Pravastatin
0.434722 	 (-): Bleeding Time
0.434722 	 (-): Leukocytes
0.434722 	 (-): Platelet Membrane Glycoproteins
0.434722 	 (-): Simvastatin
0.434475 	 (-): Thrombin
0.43398 	 (-): Drug Synergism
0.310429 	 (-): Hydroxymethylglutaryl-CoA Reductase Inhibitors
0.303065 	 (-): Heptanoic Acids
0.303065 	 (-): Pyrroles
0.294475 	 (-): Antibodies, Monoclonal
0.294475 	 (-): Immunoglobulin Fab Fragments
0.289624 	 (-): Peptide Fragments
0.27219 	 (-): Angina, Unstable P
0.265173 	 (-): Brain Ischemia
0.265173 	 (-): Fibrinogen
0.25834 	 (-): Anticoagulants
0.248699 	 (-): CD40 Ligand
0.248699 	 (-): Heparin
0.238941 	 (-): Fibrinolytic Agents
0.215311 	 (-): Blood Coagulation
0.215311 	 (-): Membrane Proteins
0.20081 	 (-): von Willebrand Factor
0.192316 	 (-): Collagen
0.189924 	 (-): Platelet Glycoprotein GPIIb-IIIa Complex
0.164021 	 (-): Smoking
0.16287 	 (-): Epinephrine
0.16287 	 (-): Peptides
0.16287 	 (-): Postoperative Complications
0.155175 	 (-): Tyrosine
0.139687 	 (-): Stroke
0.138661 	 (-): P-Selectin
0.111287 	 (-): Alprostadil
0.111287 	 (-): Anti-Inflammatory Agents, Non-Steroidal
0.111287 	 (-): Integrin beta3
0.111287 	 (-): Liver
0.101292 	 (-): Platelet Count
0.099096 	 (-): Cytochrome P-450 Enzyme System
0.093879 	 (-): 2-Pyridinylmethylsulfinylbenzimidazoles
0.093879 	 (-): Premedication
0.093879 	 (-): Research Design
0.09359 	 (-): Piperazines
0.091906 	 (-): Biological Markers
0.088721 	 (-): Thiophenes
0.087387 	 (-): C-Reactive Protein
0.083851 	 (-): Diabetes Mellitus, Type 2
0.077642 	 (-): Flow Cytometry
0.077275 	 (-): Platelet Activation
0.075582 	 (-): Angioplasty
0.075582 	 (-): Arterial Occlusive Diseases
0.075582 	 (-): Blood Glucose
0.075582 	 (-): Blood Vessel Prosthesis
0.075582 	 (-): Fatty Acids, Monounsaturated
0.075582 	 (-): Indoles
0.075582 	 (-): Ischemic Attack, Transient
0.075582 	 (-): Patient Compliance
0.075582 	 (-): Sulfonamides
0.075582 	 (-): Vasodilator Agents
0.070516 	 (-): Coronary Disease
0.054293 	 (-): Adenosine Monophosphate
0.054293 	 (-): Angioplasty, Balloon
0.054293 	 (-): Coronary Vessels
0.053736 	 (-): Coronary Artery Bypass
0.046568 	 (-): Creatine Kinase, MB Form
0.039181 	 (-): Ticlopidine
0.032847 	 (+): Electrodes
0.032847 	 (+): Mixed Function Oxygenases
0.031154 	 (-): Atrial Fibrillation
0.031154 	 (-): Blood Transfusion
0.031154 	 (-): Body Weight
0.031154 	 (-): Cardiac Surgical Procedures
0.031154 	 (-): Carotid Stenosis
0.031154 	 (-): Haplotypes
0.031154 	 (-): Hemostatics
0.031154 	 (-): Isoenzymes
0.031154 	 (-): Thrombolytic Therapy
0.031005 	 (-): Preoperative Care
0.031005 	 (-): Troponin I
0.030854 	 (-): Omeprazole
0.030392 	 (-): Electrocardiography
0.024066 	 (-): Angina Pectoris
0.014067 	 (-): Peripheral Vascular Diseases
0.013862 	 (-): Cytochrome P-450 CYP3A
0.010488 	 (-): Proton Pump Inhibitors
0.007686 	 (-): Blood Platelets
0.007209 	 (-): Aspirin
0.005332 	 (-): Myocardial Revascularization
0.005231 	 (-): Tetrazoles
9.15E-4 	 (+): Aryl Hydrocarbon Hydroxylases
4.35E-4 	 (-): Platelet Aggregation
0.0 	 (-): Acute Coronary Syndrome
0.0 	 (+): Adenosine
0.0 	 (-): Adenosine Diphosphate
0.0 	 (+): Alleles
0.0 	 (-): Angioplasty, Balloon, Coronary
0.0 	 (-): Anti-Ulcer Agents
0.0 	 (-): Aprotinin
0.0 	 (-): Arachidonic Acid
0.0 	 (-): Asian Continental Ancestry Group
0.0 	 (-): Biomarkers, Pharmacological
0.0 	 (-): Blood Coagulation Tests
0.0 	 (-): Blood Loss, Surgical
0.0 	 (-): Blood Proteins
0.0 	 (+): Body Mass Index
0.0 	 (-): Cardiac Catheterization
0.0 	 (+): Cardiovascular Diseases
0.0 	 (-): Carotid Artery, Internal
0.0 	 (+): Cell Adhesion Molecules
0.0 	 (-): Cerebrovascular Disorders
0.0 	 (-): Chemotherapy, Adjuvant
0.0 	 (-): Coronary Angiography
0.0 	 (-): Coronary Artery Bypass, Off-Pump
0.0 	 (-): Coronary Artery Disease
0.0 	 (-): Coronary Circulation
0.0 	 (-): Coronary Restenosis
0.0 	 (-): Coronary Stenosis
0.0 	 (-): Coronary Thrombosis
0.0 	 (-): DNA
0.0 	 (-): Diabetes Complications
0.0 	 (-): Drug Monitoring
0.0 	 (-): Drug Resistance
0.0 	 (-): Drug Resistance, Multiple
0.0 	 (+): Drug-Eluting Stents
0.0 	 (-): Embolization, Therapeutic
0.0 	 (-): Erythrocyte Deformability
0.0 	 (-): Esomeprazole Sodium
0.0 	 (-): Gastrointestinal Hemorrhage
0.0 	 (-): Genetic Predisposition to Disease
0.0 	 (-): Genetic Variation
0.0 	 (+): Genotype
0.0 	 (-): Glomerular Filtration Rate
0.0 	 (+): Graft Occlusion, Vascular
0.0 	 (-): Heart Diseases
0.0 	 (-): Hemorrhage
0.0 	 (+): Homozygote
0.0 	 (-): Inflammation
0.0 	 (-): Integrin alpha2
0.0 	 (-): Intracranial Thrombosis
0.0 	 (+): Ischemia
0.0 	 (+): Microfilament Proteins
0.0 	 (-): Models, Statistical
0.0 	 (-): Monitoring, Physiologic
0.0 	 (-): Mutation, Missense
0.0 	 (-): Myocardial Infarction
0.0 	 (-): Myocardial Ischemia
0.0 	 (-): Myocardium
0.0 	 (-): Nephelometry and Turbidimetry
0.0 	 (+): P-Glycoprotein
0.0 	 (+): Pharmacogenetics
0.0 	 (+): Phosphoproteins
0.0 	 (-): Platelet Aggregation Inhibitors
0.0 	 (-): Platelet Function Tests
0.0 	 (-): Platelet-Rich Plasma
0.0 	 (+): Point-of-Care Systems
0.0 	 (+): Polymorphism, Genetic
0.0 	 (-): Polymorphism, Single Nucleotide
0.0 	 (+): Predictive Value of Tests
0.0 	 (-): Prodrugs
0.0 	 (-): Prosthesis Implantation
0.0 	 (-): Protein Processing, Post-Translational
0.0 	 (-): Purinergic P2 Receptor Antagonists
0.0 	 (-): Purinergic P2Y Receptor Antagonists
0.0 	 (-): Randomized Controlled Trials as Topic
0.0 	 (-): Reagent Kits, Diagnostic
0.0 	 (-): Receptors, Purinergic P2
0.0 	 (-): Receptors, Purinergic P2Y12
0.0 	 (+): Risk Assessment
0.0 	 (-): Stents
0.0 	 (+): Surgical Procedures, Elective
0.0 	 (-): Thrombelastography
0.0 	 (-): Thrombosis
0.0 	 (-): Treatment Outcome
0.0 	 (+): Vasodilation
